Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Guardant Health Inc shares valued at $6,584 were sold by Joyce Meghan V. on Sep 02 ’25. At $65.84 per share, Joyce Meghan V. sold 100 shares. The insider’s holdings dropped to 11,183 shares worth approximately $0.73 million following the completion of this transaction.
Also, Joyce Meghan V. purchased 100 shares, netting a total of over 6,584 in proceeds.
Before that, Kalia Kumud had sold 2,000 shares from its account. In a trade valued at $123,510, the Chief Information Officer traded Guardant Health Inc shares for $61.76 each. Upon closing the transaction, the insider’s holdings decreased to 2,000 shares, worth approximately $1.2 million.
As published in their initiating research note from Mizuho on April 10, 2025, Guardant Health Inc [GH] has been an Outperform and the price target has been revised to $55. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in late January. As of June 28, 2024, Guggenheim has increased its “Neutral” rating to a “Buy” for GH.
Analyzing GH Stock Performance
On last trading session, Guardant Health Inc [NASDAQ: GH] plunged -2.18% to $65.06. The stock’s lowest price that day was $64.32, but it reached a high of $66.775 in the same session. During the last five days, there has been a surge of approximately 2.57%. Over the course of the year, Guardant Health Inc shares have jumped approximately 150.91%. Shares of the company reached a 52-week high of $68.00 on 09/02/25 and a 52-week low of $30.97 on 01/02/25.
Support And Resistance Levels for Guardant Health Inc (GH)
According to the 24-hour chart, there is a support level at 63.99, which, if violated, would cause prices to drop to 62.93. In the upper region, resistance lies at 66.45. The next price resistance is at 67.84. RSI (Relative Strength Index) is 70.30 on the 14-day chart, showing overbought technical sentiment.
Is Guardant Health Inc subject to short interest?
Stocks of Guardant Health Inc saw a sharp steep in short interest on 2025-08-15 dropping by -1.39 million shares to 8.19 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 9.58 million shares. A decline of -17.04% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.72 of the overall float, the days-to-cover ratio (short ratio) decline to 2.72.
Which companies own the most shares of Guardant Health Inc (GH)?
In terms of Guardant Health Inc share price expectations, FactSet research, analysts set an average price target of 61 in the next 12 months, down nearly -8.28% from the previous closing price of $66.51. Analysts anticipate Guardant Health Inc stock to reach 70 by 2025, with the lowest price target being 52. In spite of this, 13 analysts ranked Guardant Health Inc stock as Buy at the end of 2025. On April 24, 2024, Craig Hallum assigned a price target of “a Buy” to the stock and resumed coverage with a $28.
